Letter

Audit is important part of drug safety and regulation

BMJ 2005; 331 doi: 10.1136/bmj.331.7514.456 (Published 18 August 2005)
Cite this as: BMJ 2005;331:456.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Michael I Carter, consultant anaesthetist (Michael.Carter@ldh-tr.anglox.nhs.uk),
  2. Jane Murkin, patient safety manager
  1. Luton and Dunstable Hospital NHS Trust, Luton LU4 0DZ
  2. Luton and Dunstable Hospital NHS Trust, Luton LU4 0DZ

    EDITOR—Waller et al write about the responsibilities of the pharmaceutical companies and the regulating agencies such as the UK Medicines and Healthcare products Regulatory Agency to improve the safety of the drugs that are licensed for prescription.1 Although cyclo-oxygenase 2 inhibitors and selective serotonin reuptake inhibitors have been under the spotlight in recent months, other drugs may be of greater concern.

    In …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular